Cardiogenic shock (CS) is a cardiac emergency often leading to multiple organ failure and death. Assessing organ dysfunction and appropriate risk stratification are central for the optimal management of these patients. The purpose of this study was to assess the prevalence of abnormal liver function tests (LFTs), as well as early changes of LFTs and their impact on outcome in CS. We measured LFTs in 178 patients in CS from serial blood samples taken at 0 hours, 12 hours, and 24 hours. The associations of LFT abnormalities and their early changes with all-cause 90-day mortality were estimated using Fisher's exact test and Cox proportional hazards regression analysis. Baseline alanine aminotransferase (ALT) was abnormal in 58% of the patients, more frequently in nonsurvivors. Abnormalities in other LFTs analyzed (alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin) were not associated with short-term mortality. An increase in ALT of >20% within 24 hours (ΔALT>+20%) was observed in 24% of patients. ΔALT>+20% was associated with a more than 2-fold increase in mortality compared with those with stable or decreasing ALT (70% and 28%, p <0.001). Multivariable regression analysis showed that ΔALT>+20% was associated with increased 90-day mortality independent of other known risk factors. Abnormal liver function tests (LFTs) are a common finding in acute and chronic heart failure. Their association with worse outcomes has been well established for chronic heart failure, 1,2 but their role in acute heart failure has attracted attention only recently.
Abnormal liver function tests (LFTs) are a common finding in acute and chronic heart failure. Their association with worse outcomes has been well established for chronic heart failure, 1, 2 but their role in acute heart failure has attracted attention only recently. [3] [4] [5] [6] [7] [8] [9] [10] Despite some recent studies, the role of changes in LFTs during hospitalization for acute heart failure remains controversial. [3] [4] [5] [6] [7] Cardiogenic shock (CS) is the most severe form of acute heart failure, characterized by severe hypoperfusion caused by cardiac dysfunction despite adequate filling pressures. 11 Without prompt treatment, CS often leads into a spiral of multiple organ failure and systemic inflammatory response, eventually resulting in death. 12 abnormal LFTs indicating hepatic impairment are a common finding in critically ill patients and have been shown to be associated with a worse prognosis, [13] [14] [15] the prevalence and prognostic significance of ischemic liver injury, that is, hypoxic hepatitis, in CS has not been well studied. A recent study by Jung et al 16 showed that hypoxic hepatitis, as defined by alanine aminotransferase (ALT) levels >20 times the upper limit of normal within 72 hours of shock, was associated with higher 30-day mortality. However, the effect of more modest early increases in transaminases as well as the role of other LFT abnormalities in CS remains unstudied. The purpose of this study was to assess the prevalence of abnormal LFTs, their changes, and impact on outcome in patients in CS.
Methods
The CardShock study (NCT01374867 at www.clinicaltrials .gov) is a European prospective, observational, multicenter and multinational study on CS. Patients were recruited between October 2010 and December 2012 from emergency departments, cardiac and intensive care units, as well as catheterization laboratories in 9 tertiary hospitals from 8 countries. The study enrolled consecutive patients aged older than 18 years within 6 hours from identification of CS (for details, see Harjola et al 17 ). The inclusion criteria were (1) systolic blood pressure <90 mm Hg (after adequate fluid challenge) for 30 minutes, or need of vasopressor therapy to maintain systolic blood pressure >90 mm Hg and (2) signs of hypoperfusion (altered mental status, cold periphery, oliguria <0.5 ml/kg/h for the previous 6 hours, or blood lactate >2 mmol/L). Exclusion criteria were shock caused by ongoing hemodynamically significant arrhythmias or shock after cardiac or noncardiac surgery. The etiology of CS was determined by local investigators. Acute coronary syndrome etiology was defined as shock caused by myocardial infarction. Echocardiography was performed per protocol at study entry. Patients were treated according to local practice, and treatment and procedures were registered. Invasive hemodynamic monitoring was based on clinical evaluation and used at the discretion of the treating physician. Cardiac output was measured with the thermodilution method, using the average from 3 sequential measurements. Cardiac index was calculated by dividing the cardiac output by body surface area calculated from weight and height.
Blood sampling was performed at baseline (0 hours; n = 178) and serially at 12-hour intervals from baseline (12 hours, 24 hours; both +/−3 hours). Plasma samples were immediately frozen in aliquots and stored at −80°C. We analyzed creatinine, C-reactive protein, high-sensitivity troponin T (hsTnT), N-terminal prohormone of B-type natriuretic peptide, ALT, alkaline phosphatase, gamma-glutamyl transferase (GGT), and total bilirubin (Roche Diagnostics, Basel, Switzerland) at a central laboratory (ISLAB, Kuopio, Finland). These analyses were accredited by the Finnish Accreditation Service according to EN15189 and ISO17025. The cutoffs used to determine abnormal values for the LFTs were 35 U/L for ALT, 105 U/L for alkaline phosphatase, 60 U/L for GGT, and 25 µmol/L for bilirubin. Estimated glomerular filtration rate was calculated from creatinine values using the Chronic Kidney Disease Epidemiology Collaboration equation. 18 Arterial blood lactate was analyzed locally.
An increase in LFT values was defined as a rise by >20% from the first measurement to the highest value within 24 hours from baseline. A cutoff of >20% increase was chosen based on receiver operating characteristic curve analysis and has been used in a previous investigation on patients with acute heart failure. 5 At least 2 separate LFT values within 24 hours (0, 12, and 24 hours) were available for 156 of 178 patients. Patients with the highest LFT value in the normal range were considered to have no significant LFT increase. Sensitivity analyses were performed using different cut-off values for both the increase (>+25% within 24 hours) and the highest level within 24 hours (>2 times the upper limit of normal).
The primary end point was 90-day all-cause mortality. Vital status during follow-up was determined through direct contact with the patient or next of kin, or through population and hospital registries. Two patients were lost to follow-up. The study was approved by local ethics committees and conducted in accordance with the Declaration of Helsinki. Results are presented as numbers (n) and percentages (%), means and standard deviations, or medians and interquartile ranges for variables with a skewed distribution. Between-group comparisons were performed using Student t test or MannWhitney U test, as appropriate. Differences in categorical variables were assessed by Fisher's exact test. For differences in Kaplan-Meier survival curves, the log-rank test was used. Cox proportional hazards model analysis was used to identify variables associated with 90-day mortality. In the multivariable models, adjustment was made for the variables included in the recently published CardShock risk score, 17 that is, age, history of myocardial infarction or coronary bypass grafting, altered mental status at presentation, acute coronary syndrome etiology, left ventricular ejection fraction, lactate, and estimated glomerular filtration rate on admission. Log-minus-log plots were used to evaluate the adequacy of the proportional hazards assumption. Results from the regression analyses are presented as hazard ratios (HRs) with 95% confidence intervals. To determine independent predictors of ΔALT>+20%, baseline variables with a univariable p <0.1 were entered into a multivariable logistic regression model. Stepwise forward and backward likelihood ratio test with significance <0.05 for inclusion and >0.1 for elimination was used to determine independent predictors with a p value of <0.05 in a multivariable logistic regression model. Data were analyzed using SPSS Statistics version 23 (IBM Corp, Armonk, NY).
Results
The study cohort comprised 178 patients in CS with all LFTs (ALT, alkaline phosphatase, GGT, and bilirubin) available at baseline. The mean age was 66 (12) years, and 74% were men. On average, mean arterial pressure for all patients in the cohort was 57 (11) mm Hg. The main etiology of CS was acute coronary syndrome (80%). The 90-day allcause mortality was 42%.
In the LFTs analyzed, ALT was the most frequently abnormal, as summarized in Table 1 . Median ALT at baseline (ALT-0h) was 44 U/L, and ALT-0h was above the upper limit of normal in 102 (58%) patients. Abnormal values in other LFTs were less frequent and elevations were less prominent (Table 1) An increase in ALT of >20% within 24 hours after baseline (ΔALT>+20%) was observed in 24% of patients (37 of 154). The distribution of ALT changes within 24 hours between survivors and nonsurvivors is available in the Supplementary Material. In Kaplan-Meier analysis (Figure 1 ), ΔALT>+20% was associated with a more than 2-fold increase in 90-day mortality compared with those with no significant increase in ALT (ALT stable); 70% and 28%, p <0.001. In regression analysis, ΔALT>+20% was associated with death within 90 days, with an unadjusted HR of 3.8 (95% CI 2.2 to 6.3, p <0.001). After adjusting for ALT0h and the risk factors included in the CardShock risk score, the association remained highly significant ( Table 2 ). The association with mortality was independent of other covariates as well, including further adjustment for the peak hsTnT level within 24 hours and the change in lactate levels from baseline to 24 hours (adjusted HR 3.0, 95% CI 1.6 to 5.6, p = 0.001).
The increase in ALT within the first 24 hours was an important predictor of 90-day mortality regardless of the absolute baseline level (ALT-0h) (Figure 2 ). ΔALT>+20% was associated with increased mortality both in patients with normal and abnormal ALT-0h levels. Survival in the ALT stable group was not significantly different between patients with normal and patients with abnormal ALT-0h. Also, excluding patients who fulfilled the most commonly used criteria for hypoxic hepatitis (ALT > 20 times the upper limit of normal) did not influence the independent association between ΔALT>+20% and 90-day mortality. The observed independent association was not sensitive to variations in the cutoffs used for either ΔALT or abnormal ALT (see Methods section). There were no statistically significant associations between 90-day mortality and increases of >+20% of other LFTs within 24 hours of baseline (see Supplementary Material). Table 3 shows that in patients in CS, ΔALT>+20% was associated with oliguria and higher levels of lactate as signs of hypoperfusion, as well as lower left ventricular ejection fraction and estimated glomerular filtration rate. There were, however, no significant differences in blood pressure, heart rate, medical history, cardiovascular medications at admission, N-terminal prohormone of B-type natriuretic peptide, or etiology of CS between ΔALT>+20% and ALT stable groups. A significantly higher peak hsTnT level within 24 hours was observed in the ΔALT>+20% group. Serial central venous pressure and cardiac index measurements were available for a total of 79 and 50 patients, respectively. In the ΔALT>+20% group, the cardiac index was initially at the same level, but recovered more slowly and was significantly lower between 24 and 48 hours than ALT stable (Figure 3 ). In the ΔALT>+20% group, central venous pressure was higher between 12 hours and 24 hours, with a trend toward higher central venous pressure up to 48 hours ( Figure 3) .
In multivariable logistic regression analysis, left ventricular ejection fraction (OR 0.95, 95% CI 0.92 to 0.99, p = 0.006), mean arterial pressure (OR 0.95, 95% CI 0.90 to 0.99, p = 0.03), C-reactive protein (OR 0.98, 95% CI 0.97 to 0.99, p = 0.01), and estimated glomerular filtration rate (OR 0.98, 95% CI 0.96 to 0.99, p = 0.002) were found to be independent baseline predictors of ΔALT>+20%.
Discussion
This is the first study to investigate the role of early changes in LFTs in association with mortality in CS. The most significant finding is that even modest (>20%) early increases in ALT levels are associated with excess mortality in CS. Although elevated ALT levels were more common in patients who died during follow-up, only an increase in ALT independently predicted mortality. Second, ALT increase was associated with hypoperfusion (higher lactate, oliguria, lower left ventricular ejection fraction, and cardiac index) and higher Results shown as % for categorical, and mean (SD) or median (IQR) for continuous variables. ACEI = angiotensin-converting enzyme inhibitor; ALT = alanine aminotransferase; ARB = angiotensin receptor blocker; hsTnT = high-sensitivity troponin T; IQR = interquartile range; NT-proBNP = N-terminal prohormone of B-type natriuretic peptide. central venous pressure. Finally, baseline levels or early increases of other LFTs investigated (alkaline phosphatase, GGT, bilirubin) showed no statistically significant association with 90-day mortality.
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Abnormal ALT levels at baseline were associated with higher mortality, but this association was lost when other variables previously shown to be independently associated with mortality in CS were included in the multivariable model. This is in line with previous findings, suggesting that ALT can be used as a surrogate marker for hemodynamics in acute heart failure, but is not independently associated with mortality. 9 By contrast, in our study, increase of ALT by >20% within 24 hours was independently associated with poor survival, even after adjustment for the considerably higher lactate levels in the ΔALT>+20% group. Moreover, the effect of early ALT increase on mortality was strong regardless of baseline ALT. Baseline ALT can be elevated because of preexisting conditions (in fact, there were more patients with history of alcohol abuse in the ALT stable group). Therefore, early increases in ALT may be a more reliable indicator of hypoperfusion caused by CS. Indeed, central venous pressures and cardiac index differed between ALT stable and ΔALT>+20% groups. It seems that a stable and/or resolving ALT may reflect rapid reversal of the hypoperfusion state, whereas an increase in ALT suggests prolonged and more severe hemodynamic derangements.
In our study, independent baseline predictors of ΔALT>+20% were low left ventricular ejection fraction, low mean arterial pressure, low C-reactive protein, and low estimated glomerular filtration rate at baseline. Low left ventricular ejection fraction and low mean arterial pressure can lead to hypoperfusion-induced liver injury, causing an increase in ALT. Conversely, early liver dysfunction caused by hypoperfusion can lead to a decrease in the production of C-reactive protein in the liver. In a study of hypoxic hepatitis in cardiogenic shock, admission serum creatinine (from which estimated glomerular filtration rate is derived) was a predictor of hypoxic hepatitis in univariable analysis. 16 In addition to preexisting renal dysfunction, acute kidney injury and liver dysfunction may have similar causes in CS, as there were more patients who also developed acute kidney injury in the ΔALT>+20% group (Table 3) .
There was a significant association between ΔALT>+20% and peak hsTnT level within 24 hours. It is possible that some of the increase in ALT was cardiac in origin, as cardiac muscle has been shown to contain small amounts of ALT. 19 More likely, the observed association could be due to larger acute myocardial infarctions causing a more profound deterioration in cardiac output (as shown by the lower cardiac index in the ΔALT>+20% group), resulting in liver hypoperfusion and ALT release of hepatic origin. Nonetheless, even after adjusting for the association with peak hsTnT level within 24 hours, ΔALT>+20% was independently associated with 90-day mortality. This is in accordance with a previous study in the critically ill, where the degree of hepatic impairment (illustrated by prothrombin time) was an independent predictor of mortality in patients with hypoxic hepatitis.
14 Previous investigations on the effect of transaminase elevations (ALT, aspartate aminotransferase) in critically ill patients have focused on more marked increases. A recent meta-analysis of 24 studies on hypoxic hepatitis 20 reported that the cut-off level of transaminase elevations for the diagnosis of hypoxic hepatitis varied in investigations between >300 and >3,000. Elevations of that magnitude were rare in this cohort of CS. Modest increases, such as those observed in the present study, have previously been described to affect survival in acute heart failure 5 and in patients with acute ST-elevation myocardial infarction, 21 and even low values within the normal range have been previously shown to be associated with decreased survival in heart failure. 22 In the present study, abnormal values of bilirubin or GGT showed no association with mortality. This is in contrast to studies in acute heart failure, where it has been shown that GGT 8, 23 and total bilirubin 7 are markers of poor prognosis. Previous investigations 9, 24, 25 have also shown a link in heart failure between LFTs and central venous pressure, as well as cardiac index. We found an association between cardiac index and ALT, as well as central venous pressure and ALT, but not with total bilirubin, alkaline phosphatase, or GGT. The observed differences could be owing to the timing of the samples in relation to the nascent liver injury and differences in study populations. Most of the previous studies [3] [4] [5] 7 have excluded patients in CS and patients with acute coronary syndrome, so the results are not representative for CS, where the majority is caused by myocardial infarction. As shown by Jäger et al, 26 the laboratory pattern of jaundice and cholestasis frequently occurs several days following acute hepatic injury, whereas transaminases, such as ALT, have been shown to increase rapidly in case of hypoxic shock due to liver cell necrosis. 27 Consequently and in accordance with our data, alkaline phosphatase, GGT, and bilirubin seem not to be appropriate tools for early risk stratification in patients in CS.
Our study has several limitations. First, not all patients with values at baseline could be included in the analyses on early changes of LFTs. Some patients died already during the first 24 hours, and a few more were excluded because of missing samples. Nevertheless, considering the general challenges with serial sampling in acute cardiac care, the final cohort available for analysis of changes in LFTs is, to our knowledge, unique. Second, hemodynamic measurements were available only from a proportion of patients. The use of pulmonary artery catheter and central venous pressure measurements was at the discretion of the treating physician. Invasive hemodynamic monitoring is not routinely advocated, and we believe that our cohort reflects current clinical practice. Third, the cutoff of 20% change for ALT was extrapolated from data in acute heart failure, and needs to be confirmed by other studies. Sensitivity analyses in our cohort suggested the selected value to be clinically relevant. Finally, CS is a complex syndrome, and although adjustment for all relevant available variables was performed in mortality analyses, unaccounted differences in the treatment between survivors and nonsurvivors may remain.
In conclusion, the present study describes the prevalence and clinical importance of LFT abnormalities in CS. Although ALT levels are frequently elevated at baseline, only an increase in ALT by 20% or more within the first 24 hours was strongly and independently associated with higher 90-day mortality. The study suggests that early increases in ALT in patients in CS are related to organ hypoperfusion, as evidenced by lower cardiac index and other clinical markers of hypoperfusion. Based on these results, we suggest that serial
